Individual versus standard quality of life assessment in a phase II clinical trial in mesothelioma patients: Feasibility and responsiveness to clinical changes

Karin Ribi*, Jürg Bernhard, Jan C. Schuller, Walter Weder, Stephan Bodis, Markus Jörger, Daniel Betticher, Ralph A. Schmid, Roger Stupp, Hans Beat Ris, Rolf A. Stahel

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

20 Scopus citations

Fingerprint Dive into the research topics of 'Individual versus standard quality of life assessment in a phase II clinical trial in mesothelioma patients: Feasibility and responsiveness to clinical changes'. Together they form a unique fingerprint.

Medicine & Life Sciences